LeMaitre Vascular
LMAT
326 hedge funds and large institutions have $2.2B invested in LeMaitre Vascular in 2026 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 132 increasing their positions, 96 reducing their positions, and 49 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 96
2.87% more ownership
Funds ownership: 97.16% → 100.04% (+2.9%)
4% less funds holding
Funds holding: 340 → 326 (-14)
9% less capital invested
Capital invested by funds: $2.41B → $2.2B (-$219M)
20% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 49
43% less call options, than puts
Call options by funds: $259K | Put options by funds: $451K
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$47.2M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$21.2M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.4M |
| 4 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$13.2M |
| 5 |
BlackRock
New York
|
+$13.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$21.5M |
| 2 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$16.9M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$11.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$9.62M |
| 5 |
ACA
Aptus Capital Advisors
Fairhope,
Alabama
|
-$7.48M |
LMAT Hedge Fund Activity: Q2 2026 in Review
326 of the 8,295 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2026, worth a combined $2.2B — down 9.1% from $2.41B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of LMAT and 39 opened new positions — a net loss of 10 holders — while 96 trimmed existing stakes and 132 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $47.2M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $21.5M sold.
- 326 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2026, down from 340 in Q1 2026.
- Funds reported $2.2B of LeMaitre Vascular stock for Q2 2026, down 9.1% quarter-over-quarter.
- 39 funds opened new LeMaitre Vascular positions in Q2 2026 and 49 closed out, a net change of -10 holders.
- The largest LeMaitre Vascular buyer in Q2 2026 was T. Rowe Price Associates, an estimated $47.2M added.
- The largest LeMaitre Vascular seller in Q2 2026 was Driehaus Capital Management, an estimated $21.5M sold.
Based on aggregated 13F filings for Q2 2026.